1. Home
  2. BNR vs BTCS Comparison

BNR vs BTCS Comparison

Compare BNR & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • BTCS
  • Stock Information
  • Founded
  • BNR 2014
  • BTCS 2008
  • Country
  • BNR China
  • BTCS United States
  • Employees
  • BNR N/A
  • BTCS N/A
  • Industry
  • BNR Medical Specialities
  • BTCS Finance: Consumer Services
  • Sector
  • BNR Health Care
  • BTCS Finance
  • Exchange
  • BNR Nasdaq
  • BTCS Nasdaq
  • Market Cap
  • BNR 61.7M
  • BTCS 50.9M
  • IPO Year
  • BNR 2020
  • BTCS N/A
  • Fundamental
  • Price
  • BNR $5.66
  • BTCS $2.03
  • Analyst Decision
  • BNR
  • BTCS Strong Buy
  • Analyst Count
  • BNR 0
  • BTCS 1
  • Target Price
  • BNR N/A
  • BTCS $5.00
  • AVG Volume (30 Days)
  • BNR 5.3K
  • BTCS 324.8K
  • Earning Date
  • BNR 03-27-2025
  • BTCS 03-20-2025
  • Dividend Yield
  • BNR N/A
  • BTCS N/A
  • EPS Growth
  • BNR N/A
  • BTCS N/A
  • EPS
  • BNR N/A
  • BTCS 0.24
  • Revenue
  • BNR $72,832,704.00
  • BTCS $2,077,860.00
  • Revenue This Year
  • BNR $52.90
  • BTCS $196.95
  • Revenue Next Year
  • BNR $48.35
  • BTCS $182.05
  • P/E Ratio
  • BNR N/A
  • BTCS $8.29
  • Revenue Growth
  • BNR N/A
  • BTCS 61.78
  • 52 Week Low
  • BNR $0.57
  • BTCS $0.95
  • 52 Week High
  • BNR $8.99
  • BTCS $5.41
  • Technical
  • Relative Strength Index (RSI)
  • BNR 40.71
  • BTCS 36.13
  • Support Level
  • BNR $4.41
  • BTCS $1.78
  • Resistance Level
  • BNR $6.33
  • BTCS $2.49
  • Average True Range (ATR)
  • BNR 0.54
  • BTCS 0.22
  • MACD
  • BNR -0.16
  • BTCS -0.04
  • Stochastic Oscillator
  • BNR 35.82
  • BTCS 21.55

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About BTCS BTCS Inc.

BTCS Inc is engaged in the business of hosting an online e-commerce marketplace where consumers can purchase merchandise using Digital Assets, including bitcoin. The company focuses on blockchain and Digital Asset ecosystems. The firm operates a beta e-commerce marketplace, which accepts a range of digital currencies, has designed a beta secure digital currency storage solution BTCS Wallet.

Share on Social Networks: